Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 2 (2005), Issue 1 (January)

1. Development and validation of ELISA for herceptin detection in human serum.
   J Immunol Methods, 295(1): 169-82. [Abstract] [Full-text]
2. Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein.
   Int J Radiat Oncol Biol Phys, 61(1): 203-11. [Abstract] [Full-text]
3. Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.
   Breast Cancer Res, 7(1): R145-55. [Abstract] [Full-text]
4. Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling.
   J Biol Chem, 280(3): 2092-104. [Abstract] [Full-text]
5. Locally advanced breast cancer in octogenarian women.
   Breast Cancer Res Treat, 89(1): 81-90. [Abstract] [Full-text]
6. Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.
   Ann Oncol, 16(2): 234-9. [Abstract] [Full-text]
7. HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique.
   Urology, 65(1): 176-80. [Abstract] [Full-text]
8. Cytotoxicity of breast cancer cells overexpressing HER2/neu by (213)Bi-Herceptin radioimmunoconjugate.
   Cancer Lett, 218(2): 181-90. [Abstract] [Full-text]
9. Monoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene delivery.
   J Control Release, 102(3): 737-47. [Abstract] [Full-text]
10. A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis.
    J Immunol Methods, 296(1): 95-101. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.